Lysosomal proteome characterization during TRPML1 activation by MLSA5 in human cancer cells
Ontology highlight
ABSTRACT: To capture the changes in the lysosomal proteome upon TRPML1 activation, achieved using a small molecule agonist MLSA5, human cancer cells, with or without gene-editing, stably expressing TMEM192-mRFP-3xHA (Lyso-IP), were treated with MLSA5 and Lyso-IP samples were prepared and processed for TMT-MS analysis. Each condition was performed in triplicate.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
SUBMITTER:
Chan Lee
LAB HEAD: J. Wade Harper
PROVIDER: PXD054968 | Pride | 2025-04-22
REPOSITORIES: Pride
ACCESS DATA